FY2027 ICD-10 Orthopaedic Code Changes: What Takes Effect October 1, 2026

The FY2027 ICD-10-CM code set applies to every date of service on or after October 1, 2026. For orthopaedic practices, the practical impact is narrower than the headline numbers suggest, and sharper. The update adds 190 new billable codes, deletes 30, and revises four descriptors. Only a handful touch musculoskeletal care. Two of them will generate hard claim rejections in high-volume orthopaedic service lines on day one.

The first: plantar fasciitis moves out of M72.2 into a new M67.A- subcategory with laterality. The second: the sternoclavicular sprain codes in the S23.420- series are deleted outright. There is no grace period. A claim submitted with a deleted or newly non-billable code for an October 1 date of service will be rejected, not downcoded. If your practice treats feet, ankles, or shoulders, your work list is short but it is not optional.

What the FY2027 ICD-10-CM update actually contains

CMS and the CDC released the FY2027 ICD-10-CM files in June 2026 for the code year running October 1, 2026 through September 30, 2027. Two different sets of numbers are circulating, and both are defensible depending on what is being counted.

• 190 new billable codes, 30 deletions, and four revised descriptors. This is the count reported by ACDIS, Revenue Cycle Advisor, AGS Health, and Health Information Associates. It is the number that matters operationally, because these are the codes that hit a claim.
• 238 new tabular entries and 21 invalidated concepts. This count, reported by Wolters Kluwer and KarenZupko & Associates, includes non-billable category headers. KZA reads the 238 new entries as 190 new billable codes plus parent headers.

Neither number should drive your preparation. The chapter-level breakdown should. Per Health Information Associates' analysis of the FY2027 files, Chapter 13 (M00-M99, Diseases of the Musculoskeletal System and Connective Tissue) gains 31 new codes and loses nine to invalidation. Chapter 19 (S00-T88, Injury, Poisoning and Certain Other Consequences of External Causes) gains 60 new codes and invalidates 15.

Most of Chapter 19's additions are toxic-effect codes covering alkenes, cycloparaffins, and medetomidine, which are irrelevant to an orthopaedic practice. Chapter 13's 31 additions are almost entirely concentrated in three clinical areas that orthopaedic groups bill every week.

Change 1: Plantar fasciitis gets its own subcategory, and M72.2 stops working

This is the highest-volume change for orthopaedic and foot and ankle practices, and the one most likely to generate rejections on October 1.

Until now, plantar fasciitis and plantar fascial fibromatosis (Ledderhose disease) have shared a single code: M72.2. They are clinically distinct. One is an overuse enthesopathy, the other a benign fibrous proliferative disorder. FY2027 separates them. As AGS Health summarized the change, these conditions "are now differentiated, with new subcategory M67.A- for plantar fasciitis by foot and laterality."

The structure reported across secondary sources:

• M67.A- for plantar fasciitis, specified by foot and laterality (right, left, unspecified)
• M72.20, M72.21, M72.22 for plantar fascial fibromatosis (Ledderhose disease), unspecified, right foot, and left foot

The operational consequence

Circle this one: M72.2, a valid billable code today, becomes a non-billable parent header. Every order set, EHR favorites list, superbill, problem list, and payer authorization built on M72.2 will fail after September 30, 2026. In a practice where plantar fasciitis is a routine clinic diagnosis, this is not a rare-code edge case. It is a daily-volume code going invalid.

Two secondary actions follow. First, laterality is now mandatory for both conditions, which means clinical documentation has to specify the foot, not just the diagnosis. Second, providers who have been reflexively coding "plantar fasciitis" to M72.2 without distinguishing it from fibromatosis now make a real clinical distinction on every claim. That is exactly the kind of decision that gets made wrong at scale when it is left to a busy clinic workflow.

Verify before you build. Secondary sources consistently report the plantar fasciitis codes in a six-character form (M67.A01, M67.A02, M67.A09). Confirm the exact descriptors against the official FY2027 tabular and addenda files before you rebuild EHR favorites or payer crosswalks. The authoritative files come from CMS at cms.gov/medicare/coding-billing/icd-10-codes and from the CDC's NCHS.

Change 2: M86.8X- osteomyelitis expands by site and laterality

FY2027 expands the M86.8X- "other chronic osteomyelitis" codes by site and laterality. Under FY2026 rules, M86.8X- distinguished site only: X1 shoulder, X2 upper arm, X3 forearm, X4 hand, X5 thigh, X6 lower leg, X7 ankle and foot, X8 other site, X9 unspecified. There was no left or right specificity. FY2027 adds that specificity along with skull and facial-bone sites. The change was driven in part by the need to document Pott's puffy tumor, frontal bone osteomyelitis with subperiosteal abscess.

For orthopaedic groups the relevance is narrower than plantar fasciitis but higher-stakes per case, because it lands on periprosthetic and post-traumatic osteomyelitis documentation. If your surgeons manage infected hardware, chronic post-surgical bone infection, or diabetic foot osteomyelitis, the new laterality requirement means a note reading "chronic osteomyelitis, ankle" without a side will no longer support a specific code. These are among the highest-cost cases an orthopaedic practice manages and among the most likely to face payer scrutiny. Coding to unspecified laterality on them is avoidable audit exposure.

Change 3: The S23.420- sternoclavicular sprain codes are deleted

Of the 30 deletions in FY2027, the one that matters to orthopaedics is the removal of the S23.420- series for sternoclavicular sprain, meaning the base code plus its initial encounter (A), subsequent encounter (D), and sequela (S) extensions. AGS Health identified this as the most notable deletion in the update, and ACDIS confirmed it independently.

Note the precision. It is the S23.420- series, not the entire S23.42- subcategory. S23.42 covers sprain of the sternum generally and includes other codes, such as chondrosternal joint sprain, that remain in force.

Change 4: New codes that support orthopaedic medical necessity

Two additions outside the musculoskeletal chapters belong on your favorites lists because they strengthen documentation for surgical risk and fracture care:

• Z68.18 for body mass index (BMI) 18.4 or less, adult
• Z68.19 for body mass index (BMI) 18.5 to 19.9, adult

Low BMI is a recognized risk factor in fracture healing, osteoporosis management, and perioperative complications. Until FY2027, granularity at the low end of the BMI scale was poor. Karen Zupko & Associates specifically ties these new codes to supporting fracture care, osteoporosis management, and surgical risk documentation. In other words, they are useful for medical-necessity substantiation on exactly the cases where an orthopaedic practice is most likely to be questioned.

Chapter 13 also adds a code for VEXAS syndrome under the M04 autoinflammatory subcategory. It is a rare acquired autoinflammatory disease driven by somatic UBA1 mutations. Most orthopaedic practices will never report it, but it will appear in rheumatology-adjacent referrals.

What is not changing, and why that matters

What FY2027 leaves alone is as useful to know as what it changes. We found no identified FY2027 changes to:

• Traumatic fracture codes (S02, S22, S32, S42, S52, S62, S72, S82, S92)
• T84- complications of internal orthopaedic prosthetic devices, implants, and grafts
• M97- periprosthetic fracture
• M54- dorsalgia and the spine code families
• M75- rotator cuff disorders
• M15 through M19 osteoarthritis
• M25- other joint disorders

The FY2027 ICD-10-CM Official Guidelines for Coding and Reporting also introduced no musculoskeletal-specific changes. The guideline revisions cluster in hypertension, congenital malformations, and diethylstilbestrol exposure history.

One guideline area still deserves a second look. Section I.B.14, Documentation by Clinicians Other than the Patient's Provider, governs which clinicians' documentation can support laterality. Now that every new plantar fasciitis, fibromatosis, and osteomyelitis code requires laterality, that guideline is suddenly load-bearing for orthopaedic coding. If your medical assistants or athletic trainers are the ones documenting side in the intake note, read it before October.

There is no grace period. Plan accordingly.

This is the point most practices get wrong, usually because they remember the 2015 ICD-9 to ICD-10 transition. That transition included a one-year period of MAC audit flexibility. It was a one-time accommodation for a total code-set replacement, and it has never applied to annual updates.

In practice, that means:

• A September 30 date of service uses FY2026 codes, even if you bill it in November.
• An October 1 date of service uses FY2027 codes, even if the encounter was scheduled in August.
• Claims submitted with deleted or newly non-billable codes for post-October 1 dates of service will be rejected as unprocessable. Your options are to correct before submission or to let it reject and rework it, at roughly $25 per claim in rework cost per the most recent figure MGMA has published, sourced from Change Healthcare's 2020 Revenue Cycle Denials Index.

Your 45-day FY2027 readiness checklist

1. Pull the official files. Download the FY2027 addenda and code descriptions from CMS or the CDC's NCHS FTP. Do not build from a summary article, including this one.
2. Run a frequency report on M72.2 and S23.420-. Query the last 12 months. This tells you how much volume is exposed and whether this is a five-minute fix or a clinic-wide retraining.
3. Rebuild EHR favorites, order sets, and superbills. Every place M72.2 appears in Athena, eClinicalWorks, Epic, ModMed, NextGen, or Tebra needs to be replaced before October 1.
4. Audit your laterality documentation. Pull 20 recent plantar fasciitis and osteomyelitis notes. If laterality is missing or implied rather than stated, that is a provider-education item, not a coding item.
5. Check payer authorization files. Prior authorizations and payer policies keyed to M72.2 will need updating, and payers do not always update their own edits on time. Expect friction in October and November.
6. Brief your surgeons in one page. The clinical decisions that changed are narrow: plantar fasciitis versus Ledderhose disease, and laterality on foot and osteomyelitis diagnoses. That fits on a single sheet.

Frequently asked questions

When exactly do the FY2027 ICD-10-CM codes take effect?

October 1, 2026. The code set applies to outpatient and professional encounters occurring on or after October 1, 2026, and to inpatient discharges on or after that date, through September 30, 2027. Code selection follows the date of service or date of discharge, not the date you submit the claim.

Is there a grace period for using deleted ICD-10 codes after October 1, 2026?

No. There is no grace period for annual ICD-10-CM updates. The one-year flexibility that accompanied the 2015 ICD-9 to ICD-10 transition was a one-time accommodation and does not apply here. Claims for October 1, 2026 dates of service submitted with deleted or non-billable codes will be rejected and must be corrected and resubmitted.

What replaces M72.2 for plantar fasciitis in FY2027?

Plantar fasciitis moves to the new M67.A- subcategory, specified by foot and laterality. M72.2 becomes a non-billable parent header, and plantar fascial fibromatosis (Ledderhose disease) is reported with M72.20, M72.21, or M72.22. Confirm the exact M67.A- descriptors against the official FY2027 tabular before updating your EHR.

What replaces the deleted S23.420- sternoclavicular sprain codes?

No successor code has been identified in publicly available FY2027 summaries. Orthopaedic and sports medicine practices should locate the replacement pathway in the official FY2027 tabular and addenda before October 1 and document the decision in their coding policy. Claims submitted with S23.420, S23.420A, S23.420D, or S23.420S for post-October 1 dates of service will be rejected.

Do the FY2027 changes affect orthopaedic fracture, spine, or arthroplasty coding?

No FY2027 changes were identified in the traumatic fracture code families (S02 through S92), the T84- implant complication codes, M97- periprosthetic fracture codes, M54- dorsalgia codes, M75- rotator cuff codes, or the M15 through M19 osteoarthritis codes. The orthopaedic impact of FY2027 is concentrated in foot and ankle (plantar fasciitis), infection (osteomyelitis), and shoulder girdle injury (sternoclavicular sprain deletion).

How many codes are in the FY2027 ICD-10-CM update?

190 new billable codes, 30 deletions, and four revised descriptors, per ACDIS, Revenue Cycle Advisor, and AGS Health. A higher figure of 238 new entries also circulates. That count includes non-billable category headers alongside the 190 billable codes. For operational purposes, 190 is the number that affects claims.

Where automation changes the math

Annual code updates expose a structural weakness in manual coding workflows. The update is announced in June, takes effect October 1, and depends on every coder and every provider remembering a specific set of changes on a specific date. In practice, the changes that break claims are the ones nobody remembers: a single foot code that quietly went invalid, a sprain code deleted with no announced successor.

An autonomous coding agent that reads the note and populates the code set carries the current code year natively. It does not need to remember that M72.2 went invalid on October 1, because it never had the option of selecting it. It flags the missing laterality in the note before the claim goes out rather than after the rejection comes back. That is the difference between a code-update season that costs you two weeks of rework and one you barely notice.

See how Maia's AutoCoder handles this automatically for orthopaedic practices. Book a demo at usemaia.com.